This breakthrough research is great news for those suffering from Crohn’s Disease.
For the 565,000 Americans who suffer from Crohn’s disease, the inflammatory bowel condition that causes abdominal pain, diarrhea, weight loss and fatigue, promising new research could mean better treatments are on the horizon.The authors of the study, published in the journal mBio, identified a fungus and two bacteria that may be responsible for the development of Crohn’s Disease. Researchers are optimistic that this new information will help them design better therapies to tackle the disease.
What’s in your gut?
The study looked at the bacterial makeup of patients with Crohn’s disease, healthy family members of those patients, and also healthy strangers with no Crohn’s in their families. Researchers compared the gut profiles of those with Crohn’s disease to those living in the same household with similar genes and diets, which are also contributing factors to the development of the disease, as well as to the individuals with no family history of the disease.When analyzing fecal samples, they found high amounts of E. coli, Serratia marcescens and Candida tropicalis in the patients with Crohn’s Disease—significantly more so than in the other two groups.